698 related articles for article (PubMed ID: 11436185)
1. Assessing systemic 11beta-hydroxysteroid dehydrogenase with serum cortisone/cortisol ratios in healthy subjects and patients with diabetes mellitus and chronic renal failure.
Homma M; Tanaka A; Hino K; Takamura H; Hirano T; Oka K; Kanazawa M; Miwa T; Notoya Y; Niitsuma T; Hayashi T
Metabolism; 2001 Jul; 50(7):801-4. PubMed ID: 11436185
[TBL] [Abstract][Full Text] [Related]
2. Administration of glycyrrhetinic acid: significant correlation between serum levels and the cortisol/cortisone-ratio in serum and urine.
Heilmann P; Heide J; Hundertmark S; Schöneshöfer M
Exp Clin Endocrinol Diabetes; 1999; 107(6):370-8. PubMed ID: 10543414
[TBL] [Abstract][Full Text] [Related]
3. Cortisol, 11beta-hydroxysteroid dehydrogenases, and hypertension.
van Uum SH; Lenders JW; Hermus AR
Semin Vasc Med; 2004 May; 4(2):121-8. PubMed ID: 15478032
[TBL] [Abstract][Full Text] [Related]
4. [11 beta-hydroxysteroid dehydrogenase type 2 activity in Chilean patients with hypertension].
Mosso L; Carvajal C; Campino C; Rojas A; González A; Barraza A; Montero J; Fardella C
Rev Med Chil; 2002 Nov; 130(11):1201-8. PubMed ID: 12587501
[TBL] [Abstract][Full Text] [Related]
5. Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase.
Tomlinson JW; Stewart PM
Best Pract Res Clin Endocrinol Metab; 2001 Mar; 15(1):61-78. PubMed ID: 11469811
[TBL] [Abstract][Full Text] [Related]
6. Apparent mineralocorticoid excess.
Benediktsson R; Edwards CR
J Hum Hypertens; 1994 May; 8(5):371-5. PubMed ID: 8064785
[TBL] [Abstract][Full Text] [Related]
7. Human hypertension caused by mutations in the 11 beta-hydroxysteroid dehydrogenase gene: a molecular analysis of apparent mineralocorticoid excess.
Whorwood CB; Stewart PM
J Hypertens Suppl; 1996 Dec; 14(5):S19-24. PubMed ID: 9120678
[TBL] [Abstract][Full Text] [Related]
8. Serum cortisol/cortisone ratio after Synacthen stimulation.
Vogeser M; Zachoval R; Jacob K
Clin Biochem; 2001 Jul; 34(5):421-5. PubMed ID: 11522281
[TBL] [Abstract][Full Text] [Related]
9. Age-related changes in 11β-hydroxysteroid dehydrogenase type 2 activity in normotensive subjects.
Campino C; Martinez-Aguayo A; Baudrand R; Carvajal CA; Aglony M; Garcia H; Padilla O; Kalergis AM; Fardella CE
Am J Hypertens; 2013 Apr; 26(4):481-7. PubMed ID: 23443726
[TBL] [Abstract][Full Text] [Related]
10. Effect of hyperlipidemia on 11β-hydroxysteroid-dehydrogenase, glucocorticoid receptor, and leptin expression in insulin-sensitive tissues of cats.
Sieber-Ruckstuhl NS; Zini E; Osto M; Franchini M; Boretti FS; Meli ML; Sigrist B; Lutz TA; Reusch CE
Domest Anim Endocrinol; 2010 Nov; 39(4):222-30. PubMed ID: 20688460
[TBL] [Abstract][Full Text] [Related]
11. Characterization of 11beta-hydroxysteroid dehydrogenase activities in the renal cell line LLC-PK1: evidence for a third isoform?
Möbus E; Hermans JJ; Maser E
Endocrine; 1999 Dec; 11(3):301-7. PubMed ID: 10786827
[TBL] [Abstract][Full Text] [Related]
12. Urinary cortisol/cortisone ratios in hypertensive and normotensive cats.
Walker DJ; Elliott J; Syme HM
J Feline Med Surg; 2009 Jun; 11(6):442-8. PubMed ID: 19058985
[TBL] [Abstract][Full Text] [Related]
13. Interconversion of cortisol and cortisone by 11beta-hydroxysteroid dehydrogenases type 1 and 2 in the perfused human placenta.
Sun K; Adamson SL; Yang K; Challis JR
Placenta; 1999 Jan; 20(1):13-9. PubMed ID: 9950140
[TBL] [Abstract][Full Text] [Related]
14. 11beta-Hydroxysteroid dehydrogenase in the brain: a novel regulator of glucocorticoid action?
Seckl JR
Front Neuroendocrinol; 1997 Jan; 18(1):49-99. PubMed ID: 9000459
[TBL] [Abstract][Full Text] [Related]
15. Characterization of 11beta-hydroxysteroid dehydrogenase activity in testicular tissue of control and GnRH-immunized boars as a possible regulator of spermatogenesis.
Claus R; Wagner A; Lambert T
Exp Clin Endocrinol Diabetes; 2005 May; 113(5):262-7. PubMed ID: 15926111
[TBL] [Abstract][Full Text] [Related]
16. Cortisol and cortisone analysis in serum and plasma by atmospheric pressure photoionization tandem mass spectrometry.
Kushnir MM; Neilson R; Roberts WL; Rockwood AL
Clin Biochem; 2004 May; 37(5):357-62. PubMed ID: 15087250
[TBL] [Abstract][Full Text] [Related]
17. [A case of apparent mineralocorticoid excess caused by type 2 11 beta- hydroxysteroid dehydrogenase deficiency].
Morineau G; Pascoe L; Marc JM; Caillette A; Krozowski Z; Corvol P; Fiet J
Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1111-5. PubMed ID: 9404418
[TBL] [Abstract][Full Text] [Related]
18. 11beta-hydroxysteroid dehydrogenase activity in acromegalic patients with normal or impaired carbohydrate metabolism.
Mondok A; Varga I; Glaz E; Szucs N; Tóth M; Patocs A; Beko G; Racz K
Steroids; 2009 Sep; 74(9):725-9. PubMed ID: 19540999
[TBL] [Abstract][Full Text] [Related]
19. Distribution of glucocorticoid and mineralocorticoid receptors and 11beta-hydroxysteroid dehydrogenases in human and rat ocular tissues.
Stokes J; Noble J; Brett L; Phillips C; Seckl JR; O'Brien C; Andrew R
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1629-38. PubMed ID: 10845579
[TBL] [Abstract][Full Text] [Related]
20. Impaired protein stability of 11beta-hydroxysteroid dehydrogenase type 2: a novel mechanism of apparent mineralocorticoid excess.
Atanasov AG; Ignatova ID; Nashev LG; Dick B; Ferrari P; Frey FJ; Odermatt A
J Am Soc Nephrol; 2007 Apr; 18(4):1262-70. PubMed ID: 17314322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
